argenx SE (EBR:ARGX)
858.20
-1.20 (-0.14%)
Nov 19, 2026, 5:35 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €53.67 billion as of November 19, 2026. It is the 406th most valuable company in the world and the 3rd biggest in Belgium. Its market cap has increased by 11.21% in one year.
Market Cap
53.67B
Enterprise Value
49.15B
Revenue
5.21B
Global Rank
Country Rank
#3 Belgium
PE Ratio
33.75
ChartMarket Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 53.67B, an increase of 43,740.39%. That is a compound annual growth rate of 63.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 53.67B | 22.34% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 55.90B |
| Financière de Tubize | 10.62B |
| Hyloris Pharmaceuticals | 119.00M |
| Onward Medical | 112.78M |
| European Medical Solutions | 15.23M |
| Celyad Oncology | 6.27M |
| BioSenic | 1.31M |
| Oxurion NV | 112.59K |